- call +1-201-465-4211
- email sales@mrinsights.biz
ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning.
Scope of the Report:
This report focuses on the Attention Deficit Hyperactivity Disorder in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Attention Deficit Hyperactivity Disorder is expected to grow at a CAGR of roughly 5.8% over the next five years, will reach 23600 million US$ in 2023, from 16800 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Eli Lilly
Novartis
Shire
Pfizer
GlaxoSmithKline
Mallinckrodt
Hisamitsu
Impax
Johnson & Johnson
UCB
Purdue Parma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Stimulants Drugs
Non-stimulants Drugs
Market Segment by Applications, can be divided into
Pediatric
Adolescent
Adults
There are 15 Chapters to deeply display the global Attention Deficit Hyperactivity Disorder market.
Chapter 1, to describe Attention Deficit Hyperactivity Disorder Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Attention Deficit Hyperactivity Disorder, with sales, revenue, and price of Attention Deficit Hyperactivity Disorder, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Attention Deficit Hyperactivity Disorder, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Attention Deficit Hyperactivity Disorder market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Attention Deficit Hyperactivity Disorder sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Attention Deficit Hyperactivity Disorder Introduction
1.2 Market Analysis by Type
1.2.1 Stimulants Drugs
1.2.2 Non-stimulants Drugs
1.3 Market Analysis by Applications
1.3.1 Pediatric
1.3.2 Adolescent
1.3.3 Adults
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 Attention Deficit Hyperactivity Disorder Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly Attention Deficit Hyperactivity Disorder Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Attention Deficit Hyperactivity Disorder Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Attention Deficit Hyperactivity Disorder Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Shire
2.3.1 Business Overview
2.3.2 Attention Deficit Hyperactivity Disorder Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Shire Attention Deficit Hyperactivity Disorder Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Attention Deficit Hyperactivity Disorder Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Attention Deficit Hyperactivity Disorder Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 Attention Deficit Hyperactivity Disorder Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Mallinckrodt
2.6.1 Business Overview
2.6.2 Attention Deficit Hyperactivity Disorder Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Mallinckrodt Attention Deficit Hyperactivity Disorder Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hisamitsu
2.7.1 Business Overview
2.7.2 Attention Deficit Hyperactivity Disorder Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hisamitsu Attention Deficit Hyperactivity Disorder Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Impax
2.8.1 Business Overview
2.8.2 Attention Deficit Hyperactivity Disorder Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Impax Attention Deficit Hyperactivity Disorder Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Johnson & Johnson
2.9.1 Business Overview
2.9.2 Attention Deficit Hyperactivity Disorder Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 UCB
2.10.1 Business Overview
2.10.2 Attention Deficit Hyperactivity Disorder Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 UCB Attention Deficit Hyperactivity Disorder Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Purdue Parma
2.11.1 Business Overview
2.11.2 Attention Deficit Hyperactivity Disorder Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Purdue Parma Attention Deficit Hyperactivity Disorder Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Attention Deficit Hyperactivity Disorder Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Attention Deficit Hyperactivity Disorder Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Attention Deficit Hyperactivity Disorder Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Attention Deficit Hyperactivity Disorder Manufacturer Market Share in 2017
3.3.2 Top 6 Attention Deficit Hyperactivity Disorder Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Attention Deficit Hyperactivity Disorder Market Analysis by Regions
4.1 Global Attention Deficit Hyperactivity Disorder Sales, Revenue and Market Share by Regions
4.1.1 Global Attention Deficit Hyperactivity Disorder Sales and Market Share by Regions (2013-2018)
4.1.2 Global Attention Deficit Hyperactivity Disorder Revenue and Market Share by Regions (2013-2018)
4.2 North America Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
4.3 Europe Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
4.5 South America Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
5 North America Attention Deficit Hyperactivity Disorder by Countries
5.1 North America Attention Deficit Hyperactivity Disorder Sales, Revenue and Market Share by Countries
5.1.1 North America Attention Deficit Hyperactivity Disorder Sales and Market Share by Countries (2013-2018)
5.1.2 North America Attention Deficit Hyperactivity Disorder Revenue and Market Share by Countries (2013-2018)
5.2 United States Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
5.3 Canada Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
5.4 Mexico Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
6 Europe Attention Deficit Hyperactivity Disorder by Countries
6.1 Europe Attention Deficit Hyperactivity Disorder Sales, Revenue and Market Share by Countries
6.1.1 Europe Attention Deficit Hyperactivity Disorder Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Attention Deficit Hyperactivity Disorder Revenue and Market Share by Countries (2013-2018)
6.2 Germany Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
6.3 UK Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
6.4 France Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
6.5 Russia Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
6.6 Italy Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
7 Asia-Pacific Attention Deficit Hyperactivity Disorder by Countries
7.1 Asia-Pacific Attention Deficit Hyperactivity Disorder Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Attention Deficit Hyperactivity Disorder Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Attention Deficit Hyperactivity Disorder Revenue and Market Share by Countries (2013-2018)
7.2 China Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
7.3 Japan Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
7.4 Korea Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
7.5 India Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
8 South America Attention Deficit Hyperactivity Disorder by Countries
8.1 South America Attention Deficit Hyperactivity Disorder Sales, Revenue and Market Share by Countries
8.1.1 South America Attention Deficit Hyperactivity Disorder Sales and Market Share by Countries (2013-2018)
8.1.2 South America Attention Deficit Hyperactivity Disorder Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
8.3 Argentina Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
8.4 Colombia Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
9 Middle East and Africa Attention Deficit Hyperactivity Disorder by Countries
9.1 Middle East and Africa Attention Deficit Hyperactivity Disorder Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Attention Deficit Hyperactivity Disorder Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Attention Deficit Hyperactivity Disorder Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
9.3 UAE Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
9.4 Egypt Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
9.5 Nigeria Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
9.6 South Africa Attention Deficit Hyperactivity Disorder Sales and Growth Rate (2013-2018)
10 Global Attention Deficit Hyperactivity Disorder Market Segment by Type
10.1 Global Attention Deficit Hyperactivity Disorder Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Attention Deficit Hyperactivity Disorder Sales and Market Share by Type (2013-2018)
10.1.2 Global Attention Deficit Hyperactivity Disorder Revenue and Market Share by Type (2013-2018)
10.2 Stimulants Drugs Sales Growth and Price
10.2.1 Global Stimulants Drugs Sales Growth (2013-2018)
10.2.2 Global Stimulants Drugs Price (2013-2018)
10.3 Non-stimulants Drugs Sales Growth and Price
10.3.1 Global Non-stimulants Drugs Sales Growth (2013-2018)
10.3.2 Global Non-stimulants Drugs Price (2013-2018)
11 Global Attention Deficit Hyperactivity Disorder Market Segment by Application
11.1 Global Attention Deficit Hyperactivity Disorder Sales Market Share by Application (2013-2018)
11.2 Pediatric Sales Growth (2013-2018)
11.3 Adolescent Sales Growth (2013-2018)
11.4 Adults Sales Growth (2013-2018)
12 Attention Deficit Hyperactivity Disorder Market Forecast (2018-2023)
12.1 Global Attention Deficit Hyperactivity Disorder Sales, Revenue and Growth Rate (2018-2023)
12.2 Attention Deficit Hyperactivity Disorder Market Forecast by Regions (2018-2023)
12.2.1 North America Attention Deficit Hyperactivity Disorder Market Forecast (2018-2023)
12.2.2 Europe Attention Deficit Hyperactivity Disorder Market Forecast (2018-2023)
12.2.3 Asia-Pacific Attention Deficit Hyperactivity Disorder Market Forecast (2018-2023)
12.2.4 South America Attention Deficit Hyperactivity Disorder Market Forecast (2018-2023)
12.2.5 Middle East and Africa Attention Deficit Hyperactivity Disorder Market Forecast (2018-2023)
12.3 Attention Deficit Hyperactivity Disorder Market Forecast by Type (2018-2023)
12.3.1 Global Attention Deficit Hyperactivity Disorder Sales Forecast by Type (2018-2023)
12.3.2 Global Attention Deficit Hyperactivity Disorder Market Share Forecast by Type (2018-2023)
12.4 Attention Deficit Hyperactivity Disorder Market Forecast by Application (2018-2023)
12.4.1 Global Attention Deficit Hyperactivity Disorder Sales Forecast by Application (2018-2023)
12.4.2 Global Attention Deficit Hyperactivity Disorder Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Attention Deficit Hyperactivity Disorder Picture
Table Product Specifications of Attention Deficit Hyperactivity Disorder
Figure Global Sales Market Share of Attenti
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
